Early humoral response to COVID-19 vaccination in patients living with obesity and diabetes in France. The COVPOP OBEDIAB study with results from the ANRS0001S COV-POPART cohort

Patients with diabetes and obesity are populations at high-risk for severe COVID-19 outcomes and have shown blunted immune responses when administered different vaccines. Here we used the ‘ANRS0001S COV-POPART’ French nationwide multicenter prospective cohort to investigate early humoral response to COVID-19 vaccination in the sub-cohort (‘COVPOP OBEDIAB’) of patients with obesity and diabetes.

Source: Metabolism - Clinical and Experimental - January 30, 2023 Category: Biomedical Science Authors: Gaborit B énédicte, Fernandes Sara, Loubet Paul, Ninove Laetitia, Dutour Anne, Cariou Bertrand, Coupaye Muriel, Clement Karine, Czernichow Sébastien, Carette Claire, Resseguier Noémie, Esterle Laure, Sabrina Kali, Marie Houssays, de Lamballerie Xavier Source Type: research